OPHTHALMISCHE FORMULIERUNGEN

Patent europeic · EP3827814 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3827814
Numer da la dumonda
EP20209808
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
25-11-2020
Publitgà
02-06-2021
Concedì
17-12-2025
La protecziun finescha il pli tard
24-11-2040
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
A61K 9/14 (2006.01)
A61K 47/26 (2006.01)
A61K 47/38 (2006.01)
A61K 9/00 (2006.01)
A61K 9/08 (2006.01)
Prioritad
IT 201900022029 25.11.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-12-2025

    Represchentant inscrit

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 23.12.2025

  2. 17-12-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 17.12.2025

Partidas

Possessur

Dompé Farmaceutici S.P.A.

Dompé farmaceutici S.p.A.

Via Santa Lucia, 6, 20122 Milano, IT

Represchentant

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventur

MANTELLI, Flavio

67100 L'Aquila, IT

GENTILE, Marco Maria

67100 L'Aquila, IT

DRAGANI, Maria Concetta

67100 L'Aquila, IT

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.